Review Article
Designing Paclitaxel Drug Delivery Systems Aimed at Improved Patient Outcomes: Current Status and Challenges
Figure 5
In vitro release curves of paclitaxel loaded nanoparticles prepared under various experiment parameters (a) E5 : PLA, E7 : PLGA (75 : 25), E8 : PLGA (50 : 50); (b) ratio for PLGA-TPGS : M1 (2 : 1), M2 (1 : 1), M3 (1 : 2); (c) PLGA (75 : 25) concentration—E7: 0.125, E13: 0.188, E14: 0.25; (d) PLGA (50 : 50) concentration—E8: 0.125, E15: 0.188, E16: 0.25 (reproduced with permission from Mu and Feng, [34]).
